Bayer aims to crush consumer health rivals with $14B Merck unit buyout
06.05.2014 / Fierce Pharma
And the winner is Bayer. After months of speculation–and reported bids from the likes of Sanofi, Novartis and Reckitt Benckiser–the German drugmaker has snagged Merck's consumer health unit in a $14.2 billion deal. The consumer buyout solidifies Bayer's position at the top of the global OTC game and provides Merck with a cardio collaboration–along with a hefty chunk of change.